Status:
UNKNOWN
Anti TNF α Improves Endothelial Dysfunction in IBD Patients
Lead Sponsor:
Carmel Medical Center
Conditions:
Crohn's Disease
Eligibility:
All Genders
18-40 years
Brief Summary
Study hypothesis - this study will assess the presence of endothelial dysfunction in patients with Crohn's disease before and after 12 weeks treatment of anti TNF α.
Detailed Description
Crohn's Disease (CD) is a life long disease that mainly affects young adults. There is evidence That gut tissue injury is the result of an abnormal immune response that involved multiple non immune ce...
Eligibility Criteria
Inclusion
- Non smoker
- No history of IHD or other known risk factors for IHD
Exclusion
- Patients who had been treated with anti TNF α 4 weeks before the study
- As well as those who received corticosteroids within 1 week before the study.
- DM, IHD, CRF, SMOKER
Key Trial Info
Start Date :
May 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01881464
Start Date
May 1 2014
End Date
June 1 2018
Last Update
May 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Carmel Medical Center
Haifa, Israel